The result is a confusing landscape
Semaglutide works by: Reducing appetite by acting on receptors in the brain that control hunger and satiety Slowing gastric emptying , which helps you feel fuller for longer after meals Improving blood sugar regulation by enhancing insulin secretion when glucose levels are elevated Wegovy is administered as a once-weekly subcutaneous injection, typically starting at a low dose (0.25 mg) and gradually increasing over 16-20 weeks to the maintenance dose of 2.4 mg, as outlined in the Summary of Product Characteristics (SmPC)
Read more about testing for SIBO in my blog post
Georgios Panos Jee Sun Min, 1 Seong Jun Jo, 1, 2 Sangyoung Lee, 1 Duk Yeon Kim, 1 Da Hyun Kim, 1 Chae Bin Lee, 3 Soo Kyung Bae 1 1 College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, 14662, Republic of Korea
Overactivation, use during late-stage disease characterized by NAD + depletion, or lack of tissue specificity may result in adverse effects, including oxidative damage, energy imbalance, or cell death